Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse

Trial Profile

Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Naltrexone (Primary) ; Oxazepam (Primary) ; Metamfetamine
  • Indications Drug dependence
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Apr 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
    • 05 Apr 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
    • 03 Dec 2015 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top